Intercept Pharmaceuticals Inc

ICPT

Sector
Healthcare

Industry
Biotechnology




Buy / Sell (dollars)

1 Month

0% 0% Complete (success)
100% 100% Complete (danger)
$0.00
avg. $0.00
$70,689.91
avg. $70,689.91

Buy/Sell Ratio

0

Transactions

11

Filers

11

3 Month

24.8% 24.8% Complete (success)
75.2% 75.2% Complete (danger)
$411,750.16
avg. $137,250.05
$1.249M
avg. $416,469.10

Buy/Sell Ratio

0.33

Transactions

33

Filers

18

12 Month

0.7% 0.7% Complete (success)
99.3% 99.3% Complete (danger)
$1.217M
avg. $101,410.22
$173.194M
avg. $14.433M

Buy/Sell Ratio

0.007

Transactions

134

Filers

21

24 Month

27.4% 27.4% Complete (success)
72.6% 72.6% Complete (danger)
$67.688M
avg. $2.820M
$179.598M
avg. $7.483M

Buy/Sell Ratio

0.377

Transactions

199

Filers

22

Recent Filings - SEC Form 4


CFO Buys & Sells

The following shows events open market buys and sells made by CFOs. The CFO is likely to be the best person within a company to watch for insider signals.
On the right you can see the maximum upside and downside produced in the 7 months after the filing was made and how long it took to arrive.
These values are updated daily.

CFO data is restricted to data over 5 years old.
You need a free account to see up-to-date data.
Log in to get free access to this feature and more.

No open market CFO buys or sells found.



Filers